|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/095 | |||
| G01N 33/569 |
| (11) | Number of the document | 2612148 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11758029.0 |
| Date of filing the European patent application | 2011-09-02 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/050436 |
| Date | 2011-09-02 |
| (87) | Number | WO 2012/031271 |
| Date | 2012-03-08 |
| (30) | Number | Date | Country code |
| 380220 P | 2010-09-04 | US |
| (72) |
BALOCCHI, Cristiana, IT
LUZZI, Enrico, IT
PALUDI, Marilena, IT
GIULIANI, Marzia, Monica, IT
DONNELLY, John, US
MORI, Elena, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES |
| BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES |